Op2Lysis to acquire license from CARLINA Technologies to secure and strengthen O2L-001 IP

Op2Lysis to acquire license from CARLINA Technologies to secure and strengthen O2L-001 IP

Op2Lysis SAS announced the signature of a license agreement with CARLINA Technologies for exploiting its PEPTIDOTSTM technology.

Read the press release below for more information

About the author

Jérôme PARCQ administrator